Pseudomyxoma peritonei laboratory findings

Jump to navigation Jump to search

Pseudomyxoma peritonei Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Pseudomyxoma peritonei from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pseudomyxoma peritonei laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pseudomyxoma peritonei laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pseudomyxoma peritonei laboratory findings

CDC on Pseudomyxoma peritonei laboratory findings

Pseudomyxoma peritonei laboratory findings in the news

Blogs on Pseudomyxoma peritonei laboratory findings

Directions to Hospitals Treating Pseudomyxoma peritonei

Risk calculators and risk factors for Pseudomyxoma peritonei laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Nima Nasiri, M.D.[2]

Overview

The laboratory findings associated with pseudomyxoma peritonei are increased levels of tumor markers such as carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), carbohydrate antigen 125 (CA125).

Laboratory Findings

The laboratory findings associated with pseudomyxoma peritonei are increased levels of tumor markers such as:[1][2]

These tumor markers are useful for postoperative follow-up and prediciton of the completeness of cytoreductive surgery.[1]

References

  1. 1.0 1.1 Baratti D, Kusamura S, Martinetti A, Seregni E, Laterza B, Oliva DG, Deraco M (August 2007). "Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy". Ann. Surg. Oncol. 14 (8): 2300–8. doi:10.1245/s10434-007-9393-9. PMID 17510772.
  2. Alexander-Sefre F, Chandrakumaran K, Banerjee S, Sexton R, Thomas JM, Moran B (July 2005). "Elevated tumour markers prior to complete tumour removal in patients with pseudomyxoma peritonei predict early recurrence". Colorectal Dis. 7 (4): 382–6. doi:10.1111/j.1463-1318.2005.00773.x. PMID 15932563.


Template:WikiDoc Sources